Product Code: ETC397310 | Publication Date: Jun 2023 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 250 | No. of Figures: 50 | No. of Tables: 25 |
The Europe animal vaccines market is expected to reach USD 5.0 billion by 2027, growing at a CAGR of 8.9% over the forecast period 2021-2027. Growing adoption of animal vaccinations and increasing focus on preventive healthcare for animals are key factors driving the growth of this market across Europe region. The rising demand for pet insurance and increasing awareness about zoonotic diseases are also fuelling the growth of Europe Animal Vaccines Market during the forecast period 2021?2027.
Rapidly evolving technology has enabled increased production efficiency as well as reduced capital investments in manufacturing facilities for vaccine production, resulting in cost-effective approaches for producing high quality vaccines with improved efficacy, safety, and stability profiles. Furthermore, collaborations between private organizations as well as government initiatives have provided access to new technologies that help boost vaccine development efforts against various infectious diseases found in farm animals such as avian flu (H5N1), classical swine fever (CSF), bovine tuberculosis (BTB) etc., thereby accelerating market growth over the upcoming years.
The major players operating within this space include Zoetis Inc., Merck & Co., Boehringer Ingelheim International GmbH, Phibro Animal Health Corporation; Elanco Animal Health Inc.; Virbac SA; Ceva Sante Animale S A S.; Bayer AG; Vetoquinol SA; Huvepharma NV ; Takara Bio Inc.; Biogenesis Bago SRL among others
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Animal Vaccines Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Animal Vaccines Market Revenues & Volume, 2020 & 2027F |
3.3 Europe Animal Vaccines Market - Industry Life Cycle |
3.4 Europe Animal Vaccines Market - Porter's Five Forces |
3.5 Europe Animal Vaccines Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Europe Animal Vaccines Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.7 Europe Animal Vaccines Market Revenues & Volume Share, By Animal Type, 2020 & 2027F |
3.8 Europe Animal Vaccines Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
4 Europe Animal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Animal Vaccines Market Trends |
6 Europe Animal Vaccines Market, 2017 - 2027 |
6.1 Europe Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
6.2 Europe Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
6.3 Europe Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
7 Germany Animal Vaccines Market, 2017 - 2027 |
7.1 Germany Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
7.2 Germany Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
7.3 Germany Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
8 United Kingdom Animal Vaccines Market, 2017 - 2027 |
8.1 United Kingdom Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
8.2 United Kingdom Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
8.3 United Kingdom Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
9 France Animal Vaccines Market, 2017 - 2027 |
9.1 France Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
9.2 France Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
9.3 France Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
10 Italy Animal Vaccines Market, 2017 - 2027 |
10.1 Italy Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
10.2 Italy Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
10.3 Italy Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
11 Russia Animal Vaccines Market, 2017 - 2027 |
11.1 Russia Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
11.2 Russia Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
11.3 Russia Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
12 Spain Animal Vaccines Market, 2017 - 2027 |
12.1 Spain Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
12.2 Spain Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
12.3 Spain Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
13 Rest of Europe Animal Vaccines Market, 2017 - 2027 |
13.1 Rest of Europe Animal Vaccines Market, Revenues & Volume, By Product, 2017 - 2027 |
13.2 Rest of Europe Animal Vaccines Market, Revenues & Volume, By Animal Type, 2017 - 2027 |
13.3 Rest of Europe Animal Vaccines Market, Revenues & Volume, By Route of Administration, 2017 - 2027 |
14 Europe Animal Vaccines Market Key Performance Indicators |
15 Europe Animal Vaccines Market - Opportunity Assessment |
15.1 Europe Animal Vaccines Market Opportunity Assessment, By Countries, 2020 & 2027F |
15.2 Europe Animal Vaccines Market Opportunity Assessment, By Product, 2020 & 2027F |
15.3 Europe Animal Vaccines Market Opportunity Assessment, By Animal Type, 2020 & 2027F |
15.4 Europe Animal Vaccines Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
16 Europe Animal Vaccines Market - Competitive Landscape |
16.1 Europe Animal Vaccines Market Revenue Share, By Companies, 2020 |
16.2 Europe Animal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Company Profiles |
18 Recommendations |
19 Disclaimer |